McKesson Gross Margin 2010-2022 | MCK

Current and historical gross margin for McKesson (MCK) over the last 10 years. The current gross profit margin for McKesson as of June 30, 2022 is %.
McKesson Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2022-06-30 $268.45B $13.12B 4.89%
2022-03-31 $263.97B $13.13B 4.97%
2021-12-31 $257.01B $13.11B 5.10%
2021-09-30 $250.99B $12.83B 5.11%
2021-06-30 $245.22B $12.48B 5.09%
2021-03-31 $238.23B $12.15B 5.10%
2020-12-31 $237.62B $12.19B 5.13%
2020-09-30 $234.19B $12.07B 5.15%
2020-06-30 $231.00B $11.94B 5.17%
2020-03-31 $231.05B $12.02B 5.20%
2019-12-31 $224.95B $11.89B 5.28%
2019-09-30 $221.98B $11.83B 5.33%
2019-06-30 $217.44B $11.76B 5.41%
2019-03-31 $214.32B $11.75B 5.48%
2018-12-31 $213.52B $11.63B 5.45%
2018-09-30 $210.93B $11.37B 5.39%
2018-06-30 $209.91B $11.40B 5.43%
2018-03-31 $208.36B $11.18B 5.37%
2017-12-31 $205.44B $10.91B 5.31%
2017-09-30 $201.96B $11.00B 5.45%
2017-06-30 $199.85B $10.92B 5.47%
2017-03-31 $198.53B $11.27B 5.68%
2016-12-31 $196.50B $11.33B 5.76%
2016-09-30 $194.27B $11.39B 5.86%
2016-06-30 $193.07B $11.48B 5.94%
2016-03-31 $190.88B $11.42B 5.98%
2015-12-31 $189.13B $11.48B 6.07%
2015-09-30 $187.72B $11.51B 6.13%
2015-06-30 $183.12B $11.53B 6.29%
2015-03-31 $179.05B $11.41B 6.37%
2014-12-31 $171.95B $11.05B 6.42%
2014-09-30 $159.80B $10.00B 6.26%
2014-06-30 $148.63B $9.15B 6.16%
2014-03-31 $137.39B $8.35B 6.08%
2013-12-31 $130.20B $7.79B 5.99%
2013-09-30 $126.97B $7.59B 5.98%
2013-06-30 $123.74B $7.25B 5.86%
2013-03-31 $122.20B $6.88B 5.63%
2012-12-31 $122.84B $6.57B 5.35%
2012-09-30 $122.58B $6.49B 5.29%
2012-06-30 $123.04B $6.45B 5.25%
2012-03-31 $122.32B $6.40B 5.23%
2011-12-31 $119.89B $6.47B 5.40%
2011-09-30 $117.30B $6.37B 5.43%
2011-06-30 $114.61B $6.09B 5.31%
2011-03-31 $112.08B $5.97B 5.33%
2010-12-31 $109.87B $5.80B 5.28%
2010-09-30 $109.90B $5.80B 5.27%
2010-06-30 $109.50B $5.77B 5.27%
2010-03-31 $108.70B $5.68B 5.22%
2009-12-31 $108.28B $5.56B 5.13%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $50.991B $263.966B
McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $72.810B 21.15
AmerisourceBergen (ABC) United States $30.314B 13.39
West Pharmaceutical Services (WST) United States $24.398B 37.15
Laboratory Of America Holdings (LH) United States $23.439B 10.25
Cardinal Health (CAH) United States $16.828B 12.92
Cooper (COO) United States $16.065B 24.73
CONMED (CNMD) United States $2.967B 29.25
Invacare (IVC) United States $0.033B 0.00